Alembic Pharmaceuticals gets revision in credit ratings

From CRISIL

Alembic Pharmaceuticals has received revision in credit ratings from CRISIL as under -

CRISIL has upgraded the Credit Rating of Long-term bank facilities from 'CRISIL AA/Positive' to 'CRISIL AA+/Stable' for Rs. 315 crore limit of fund/non-fund based facilities of the Company.

CRISIL has reaffirmed the Credit Rating of CRISIL A1+ (Short-term debt including Commercial Paper) for Rs. 200 crore limit of fund based facilities of the Company.

Powered by Capital Market - Live News